Experimental PCEP-Adjuvanted Swine Influenza H1N1 Vaccine Induced Strong Immune Responses but Did Not Protect Piglets against Heterologous H3N2 Virus Challenge
Vaccination is the most efficient method of protection against influenza infections. However, the rapidly mutating viruses and development of new strains make it necessary to develop new influenza vaccines annually. Hence, vaccines that stimulate cross-protection against multiple influenza subtypes...
Main Authors: | Royford Bundi Magiri, Ken John Lai, George Kiremu Mutwiri, Heather Lynne Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/2/235 |
Similar Items
-
Caspase-1 Dependent IL-1β Secretion and Antigen-Specific T-Cell Activation by the Novel Adjuvant, PCEP
by: Sunita Awate, et al.
Published: (2014-06-01) -
Polyphosphazenes as Adjuvants for Animal Vaccines and Other Medical Applications
by: Dylan J. Chand, et al.
Published: (2021-03-01) -
Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP
by: Sarah M. Valencia, et al.
Published: (2021-08-01) -
Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge
by: Andrey Romanyuk, et al.
Published: (2022-12-01) -
Chemistry and applications of polyphosphazenes /
by: 265348 Allcock, Harry R.
Published: (2003)